The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer-Reference-Cited by-同舟云学术

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer

Published:2010-03-05 Issue:3 Volume:120 Page:655-661
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Knauer Michael,Mook Stella,Rutgers Emiel J. T.,Bender Richard A.,Hauptmann Michael,van de Vijver Marc J.,Koornstra Rutger H. T.,Bueno-de-Mesquita Jolien M.,Linn Sabine C.,van ’t Veer Laura J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-010-0814-2.pdf

Reference38 articles.

1. Trialists’ Collaborative Group (EBCTCG) et al (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717

2. National Comprehensive Cancer Network. Practice Guidelines in Oncology—v.1.2010. http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf . 12-11-2009

3. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20(8):1319–1329

4. Dowsett M, Goldhirsch A, Hayes DF, Senn HJ, Wood W, Viale G (2007) International Web-based consultation on priorities for translational breast cancer research. Breast Cancer Res 9(6):R81

5. van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530–536

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introducing effective genes in lymph node metastasis of breast cancer patients using SHAP values based on the mRNA expression data;PLOS ONE;2024-08-16

2. Cox proportional hazards regression in small studies of predictive biomarkers;Scientific Reports;2024-06-20

3. Circulating tumor DNA: from discovery to clinical application in breast cancer;Frontiers in Immunology;2024-04-30

4. A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands;Journal of Medical Economics;2024-03-12

5. Using MammaPrint on core needle biopsy to guide the need for axillary staging during breast surgery;Surgery;2024-03